The Patent Finder

Astex Therapeutics Limited

Also on record
Records under this name other than the patents Astex Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 67 patents it holds.

Back to Astex Therapeutics Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,324,225Pyrrolopyrimidine Compounds and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,416,136Pyrrolopyrimidine Compounds and Their Uses
Held by another company
In force
 · High confidence
In forceHigh confidence
US 8,962,630Pyrrolopyrimidine Compounds and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,685,980Pyrrolopyrimidine Compounds and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,193,732Salt(S) of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide and Processes of Making Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,868,739Salt(S) of 7-Cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic Acid Dimethylamide and Processes of Making Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,415,355Pyrrolopyrimidine Compounds and Their Uses
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,144,731NRF2 Regulators
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,604,509Nrf2 REGULATORS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,526,311Isoindolinone Inhibitors of the MDM2-P53 Interaction Having Anticancer Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 75 patents shown.
Pro members see all 75.
Pro members: see all 75 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited